Journal of Shanghai Jiao Tong University (Medical Science) ›› 2026, Vol. 46 ›› Issue (7): 847-856.doi: 10.3969/j.issn.1674-8115.2026.07.003

• Frontier review • Previous Articles    

Review of indication stratification and clinical strategies for endoscopic ultrasound-guided pancreatic duct drainage

Chang Yuxin, Li Baiwen(), Ni Jianbo()   

  1. Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201620, China
  • Received:2026-03-09 Accepted:2026-04-09 Online:2026-07-07 Published:2026-07-07
  • Contact: Li Baiwen, Ni Jianbo E-mail:libaiwensh@163.com;jianbo.ni@shgh.cn
  • Supported by:
    Science and Technology Innovation Action Plan of Shanghai Municipal Science and Technology Commission(23Y11902000);Shanghai Hospital Development Center, the Second Round of the Three-Year Action Plan (2023—2025) for Promoting Clinical Skills and Clinical Innovation in Municipal Hospitals Clinical Research Data Sharing and Simulated RCT Project(SHDC2024CRI049);“Two-hundred Talents” Program of Shanghai Jiao Tong University School of Medicine(20240813);Fundamental Research Funds for Central Universities(YG2023QNB17)

Abstract:

Endoscopic ultrasound-guided pancreatic duct drainage (EUS-PD/EUS-PDD) represents a major advancement in therapeutic endoscopy for pancreatic duct disorders. It is primarily indicated for patients with symptomatic pancreatic duct obstruction in whom endoscopic retrograde pancreatography (ERCP) has failed or is not feasible. The procedure involves transmural puncture of the main pancreatic duct via the stomach, duodenum, or postsurgical jejunal limb, followed by guidewire placement, tract dilation, and stent insertion to achieve ductal decompression and restoration of pancreatic juice drainage. Systematic reviews and meta-analyses have reported an overall technical success rate of 84.8%, a clinical success rate of 89.2%, and an overall adverse event rate of 18.1%, indicating substantial efficacy with non-negligible risks. The common indications for EUS-PD include pancreatic duct disruption due to pancreatic trauma, pancreatic duct injury associated with pancreatic surgery, pancreatic duct disruption secondary to severe acute pancreatitis, and surgically altered anatomy. Complications mainly include post-procedural pancreatitis, bleeding, perforation, and stent-related dysfunction. This review constructs an evidence chain covering indication stratification, procedural approaches, key techniques, complication management, long-term follow-up, and reintervention strategies, aiming to provide a reproducible clinical decision-making framework for the implementation of EUS-PD in endoscopic centers in China.

Key words: endoscopic ultrasound, pancreatic duct drainage, chronic pancreatitis, surgically altered anatomy, endoscopic ultrasound-guided rendezvous

CLC Number: